The delivery of new tuberculosis vaccines to people living with HIV – when to vaccinate? by Tom Sumner, Rebecca A. Clark, Tomos O. Prys-Jones, Roel Bakker, Gavin Churchyard, Richard G. White

Get full text

Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review. by Joeri S Buis, Degu Jerene, Agnes Gebhard, Roel Bakker, Arman Majidulla, Andrew D Kerkhoff, Rupali J Limaye, Puck T Pelzer

Get full text

Cost-effectiveness of tuberculosis infection screening and treatment among high-tuberculosis risk immigrants and asylum seekers in The Netherlands: A cohort modelling study by Jan A.C. Hontelez, Ineke T. Spruijt, Roel Bakker, Frank Cobelens, Connie Erkens, Susan van den Hof, Sake J. de Vlas

Get full text

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? by Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng

Get full text

Modelling the effect of a nutritional shock on tuberculosis in India by Rebecca A. Clark, Roel Bakker, Peter Alexander, Roslyn Henry, Richard G. White, Pranay Sinha, Rein M. G. J. Houben, C. Finn McQuaid

Get full text

Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. by Jan A C Hontelez, Mark N Lurie, Till Bärnighausen, Roel Bakker, Rob Baltussen, Frank Tanser, Timothy B Hallett, Marie-Louise Newell, Sake J de Vlas

Get full text

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. by Allison Portnoy, Jean-Louis Arcand, Rebecca A Clark, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G White, Nicolas A Menzies

Get full text

The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases. by William K Redekop, Edeltraud J Lenk, Marianne Luyendijk, Christopher Fitzpatrick, Louis Niessen, Wilma A Stolk, Fabrizio Tediosi, Adriana J Rijnsburger, Roel Bakker, Jan A C Hontelez, Jan H Richardus, Julie Jacobson, Sake J de Vlas, Johan L Severens

Get full text

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. by Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies

Get full text